Atlas Trials

Smell in COVID-19 and Efficacy of Nasal Theophylline (SCENT 3)

Clinical trial NCT05947643 · COMPLETED

Trial details

NCT number
NCT05947643
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2022-11-22
Primary completion
2025-04-24
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.